Rungnapha Saeeng Selected Research

Rungnapha Saeeng Research Topics

13	Neoplasms (Cancer) 06/2022 - 01/2012
5	Cholangiocarcinoma 01/2021 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 10/2018 - 01/2018
1	Obesity 01/2023
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Hepatocellular Carcinoma (Hepatoma) 04/2022
1	COVID-19 01/2022
1	Primary Effusion Lymphoma 12/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Neuroblastoma 01/2021
1	Carcinogenesis 05/2018
1	Colonic Neoplasms (Colon Cancer) 05/2018
1	Stomach Neoplasms (Stomach Cancer) 10/2017

12	andrographolideIBA 06/2022 - 01/2012
3	Antineoplastic Agents (Antineoplastics)IBA 10/2018 - 04/2013
2	MicellesIBA 04/2022 - 01/2016
2	acanthoic acidIBA 12/2021 - 01/2021
2	CateninsIBA 05/2018 - 01/2018
2	GlycosidesIBA 01/2018 - 11/2016
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2014 - 04/2013
2	DiterpenesIBA 12/2013 - 01/2012
2	LactonesIBA 12/2013 - 01/2012
1	LipidsIBA 01/2023
1	Small Interfering RNA (siRNA)IBA 06/2022
1	Messenger RNA (mRNA)IBA 06/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 04/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	VaccinesIBA 01/2022
1	GlucosidasesIBA 10/2021
1	ellipticineIBA 01/2021
1	propargylamineIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ChitosanIBA 10/2018
1	IridoidsIBA 01/2018
1	CinnamatesIBA 01/2018
1	durantoside IIBA 01/2018
1	Calcibiotic Root Canal SealerIBA 01/2018
1	SugarsIBA 01/2018
1	14-deoxy-11,12-didehydroandrographolideIBA 12/2017
1	Cytotoxins (Cytolysins)IBA 12/2017
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2017
1	TriazolesIBA 11/2016
1	Ether (Diethyl Ether)IBA 01/2012

3	Drug Therapy (Chemotherapy) 05/2018 - 01/2016
2	Therapeutics 06/2022 - 01/2021